{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:13:21Z","timestamp":1790097201689,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.vph.2015.08.012","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T02:01:05Z","timestamp":1439949665000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A\/NF-\u03baB\/LOX-1 pathway"],"prefix":"10.1016","volume":"85","author":[{"given":"Bo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.08.012_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0891-5849(95)02173-6","article-title":"The role of oxidized lipoproteins in atherogenesis","volume":"20","author":"Berliner","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2015.08.012_bb0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/med.20118","article-title":"Macrophages: an elusive yet emerging therapeutic target of atherosclerosis","volume":"28","author":"Tiwari","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.vph.2015.08.012_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature06803","article-title":"Imaging of atherosclerotic cardiovascular disease","volume":"451","author":"Sanz","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vph.2015.08.012_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.08.012_bb0025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2015.08.012_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/386073a0","article-title":"An endothelial receptor for oxidized low-density lipoprotein","volume":"386","author":"Sawamura","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.vph.2015.08.012_bb0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm1102-1235","article-title":"The macrophage foam cell as a target for therapeutic intervention","volume":"8","author":"Glass","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2015.08.012_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCRESAHA.109.201590","article-title":"Activation and signaling by the AMP-activated protein kinase in endothelial cells","volume":"105","author":"Fisslthaler","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2015.08.012_bb0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.vph.2015.08.012_bb0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pharmthera.2010.11.002","article-title":"AMPK and vasculoprotection","volume":"131","author":"Ewart","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vph.2015.08.012_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-511X-10-67","article-title":"A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells","volume":"10","author":"Lian","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.vph.2015.08.012_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2011.09.001","article-title":"The adenosine derivative 2\u2032,3\u2032,5\u2032-tri-O-acetyl-N6-(3-hydroxylaniline) adenosine activates AMPK and regulates lipid metabolism in vitro and in vivo","volume":"90","author":"Guo","year":"2012","journal-title":"Life Sci."},{"issue":"Pt 3","key":"10.1016\/j.vph.2015.08.012_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj3450437","article-title":"The regulation of AMP-activated protein kinase by phosphorylation","volume":"345","author":"Stein","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.vph.2015.08.012_bb0070","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1161\/CIRCULATIONAHA.105.581892","article-title":"The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus","volume":"112","author":"Zuccollo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.08.012_bb0075","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","article-title":"Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.vph.2015.08.012_bb0080","doi-asserted-by":"crossref","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","article-title":"Characterization of the AMP-activated protein kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase","volume":"271","author":"Hawley","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2015.08.012_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","article-title":"Nuclear factor-kappaB: its role in health and disease","volume":"82","author":"Kumar","year":"2004","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.vph.2015.08.012_bb0090","doi-asserted-by":"crossref","first-page":"30353","DOI":"10.1074\/jbc.274.43.30353","article-title":"IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain","volume":"274","author":"Sakurai","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2015.08.012_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(00)81688-8","article-title":"Signaling\u20132000 and beyond","volume":"100","author":"Hunter","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.vph.2015.08.012_bb0100","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/cdd.2008.98","article-title":"Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor","volume":"15","author":"Barisic","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.vph.2015.08.012_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/biof.5520110305","article-title":"Scavenger receptor regulation and atherosclerosis","volume":"11","author":"Zingg","year":"2000","journal-title":"Biofactors"},{"key":"10.1016\/j.vph.2015.08.012_bb0110","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/j.1582-4934.2010.01179.x","article-title":"Protective effects of AMP-activated protein kinase in the cardiovascular system","volume":"14","author":"Xu","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2015.08.012_bb0115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.vph.2015.08.012_bb0120","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1242\/jcs.020917","article-title":"Oxidised LDL internalisation by the LOX-1 scavenger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2","volume":"121","author":"Murphy","year":"2008","journal-title":"J. Cell Sci."},{"issue":"5-6","key":"10.1016\/j.vph.2015.08.012_bb0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.vph.2013.10.003","article-title":"LOX-1: a male hormone-regulated scavenger receptor for atherosclerosis","volume":"59","author":"Gao","year":"2013","journal-title":"Vasc. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2015.08.012_bb0130","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1002\/mnfr.201100147","article-title":"Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK\/PKC\/NADPH oxidase signaling pathway","volume":"55","author":"Tsai","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.vph.2015.08.012_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0006-2952(98)00313-X","article-title":"The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin","volume":"57","author":"Draude","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.vph.2015.08.012_bb0140","doi-asserted-by":"crossref","first-page":"33702","DOI":"10.1074\/jbc.273.50.33702","article-title":"Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene","volume":"273","author":"Nagase","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2015.08.012_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","article-title":"AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan","volume":"89","author":"Salminen","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.vph.2015.08.012_bb0150","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"Kanters","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2015.08.012_bb0155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-05-1450","article-title":"Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype","volume":"103","author":"Kanters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vph.2015.08.012_bb0160","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/eurheartj\/ehq107","article-title":"SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis","volume":"31","author":"Stein","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2015.08.012_bb0165","doi-asserted-by":"crossref","first-page":"21341","DOI":"10.1074\/jbc.M110.104224","article-title":"Protein phosphatase 2A acts as a mitogen-activated protein kinase 3 (MEKK3) phosphatase to inhibit lysophosphatidic acid-induced IkappaB kinase beta\/nuclear factor-kappaB activation","volume":"285","author":"Sun","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2015.08.012_bb0170","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1074\/jbc.M110.123968","article-title":"Andrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells","volume":"286","author":"Hsieh","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T15:02:06Z","timestamp":1567090926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115001986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"alternative-id":["S1537189115001986"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.08.012","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A\/NF-\u03baB\/LOX-1 pathway","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}